Life Science Pharmacy Recalls HCG Sublingual Drops Due to Penicillin Contamination
Life Science Pharmacy Inc. is recalling Human Chorionic Gonadotropin (HCG) sublingual drops due to potential penicillin cross-contamination. The recall covers all lots distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a high-risk allergen (penicillin) in a drug product where injury has not yet been reported, fitting the criteria for a High severity score.
Plain-English summary
Life Science Pharmacy Inc. is recalling Human Chorionic Gonadotropin (HCG) Sublingual Drops, a prescription compounded product. The recall is being conducted because the product is potentially contaminated with penicillin due to cross-contamination.
The recall includes all lots of the product. The distribution pattern is listed as nationwide. The source text does not specify the number of units affected or the specific dates of distribution.
Consumers who have purchased this product should stop using it and contact their healthcare provider or the recalling firm for further instructions. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- HUMAN CHORIONIC GONADOTROPIC (HCG) Sublingual Drops, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY
- Manufacturer
- Life Science Pharmacy Inc
- Category
- Drug — Compounded Prescription
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 23 recalled by Life Science Pharmacy Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Life Science Pharmacy Inc
See all →- HighLife Science Pharmacy Recalls Compounded Estriol Suppositories Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls TRI-EST Lozenges Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls HCG Injections Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- HighLife Science Pharmacy Recalls Compounded Estriol Vaginal Creams
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls Compounded Estriol Creams Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
Same hazard · penicillin contamination
See all →- SevereGlaxoSmithKline Recalls Bactroban Nasal Ointment Due to Penicillin Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereLife Science Pharmacy Recalls BI-EST Capsules Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
Similar recalls
- SevereFDA Recalls Chorionic Gonadotropin Injectable Due to Penicillin Contamination
FDA (Drugs) · 2015-09-09
- SevereCustomceutical Compounding Recalls HCG Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SeverePerry Drug Recalls Human Chorionic Gonadotropin Injections for Sterility Concerns
FDA (Drugs) · 2014-12-03
- SevereSynergy Rx Recalls Human Chorionic Gonadotropin Tablets Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- SevereAttix Pharmaceuticals Recalls Cetirizine HCI Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Tetracaine HCl Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29